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Unsatisfactory immediate function of the transplanted liver together with technical complications
contribute to a persisting early mortality for hepatic transplantation in the 20% range. We report our
initial clinical experience with methods, one not previously used clinically, that resulted in uniformly well-
functioning liver grafts in 11 patients and contributed to a satisfactory success rate for the procedure.
Donors were heart-beating. During the donor operation all manipulations of the liver were avoided until
after cold preservation, achieved by external cooling at the same time as circulatory interruption, donor
exsanguination and,perfusion of the liver with cold oxygenated fluid of "extracellular" type. The organs
were then gently dissected. At transplantation the livers were revascularized with arterial blood shunted
from the recipient iliac artery to the graft portal vein after completion of the suprahepatic IVC
anastomosis. The infrahepatic IVCs and hepatic arteries were then joined, the iliac artery shunts
discontinued and the portal veins joined. Total ischaemic intervals for the allografts were 31/2-8 (average
5). Anhepatic intervals were 1-21/4 (average 2). The arterio-portal shunts were operating for 18-85 (mean
46) min. Blood loss and haemodynamic, acid-base and electrolyte abnormalities at revascularization were
minimal. All grafts secreted bile immediately and all parameters reflected continuing improvement of
liver function thereafter. Nine patients (82%) are alive between 4 and 18 (mean 11) months after
transplantation. We conclude that these methods offer effective avoidance of serious organ damage
during donor hepatectomy and preservation, reduced allograft ischaemic interval and reduced recipient
anhepatic time. They result in avoidance of blood loss at the time of revascularization, together with
minimal haemodynamic, acid-base or biochemical changes. In addition, they allow the surgeon to
perform and test all anastomoses without time constraints, provide the capability to deal with unexpected
complications, and assure good early graft function.
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INTRODUCTION
The results of liver transplantation have improved remarkably in recent years.
Nevertheless, perioperative mortality remains in the range 6-30% even in the hands
of experienced groups1-4. A feared and often fatal complication is unsatisfactory
immediate function of the transplanted liver. The incidence of this complication
varies considerably from centre to centre and, in individual centres, from time to
time. Shaw et al. 5, in analyzing the Pittsburgh experience since the introduction of
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cyclosporin, reported a primary non-function rate of 4.3%. Kormos et al. 6 recording
the results of multiple organ procurement in the Pittsburgh region, reported that five
(13%) of 49 livers failed to function and a further two had late function.
Scharschmidt 7 analyzed the causes of death that occured in 51% of 540 patients who
received liver grafts in four major centres (Pittsburgh, Cambridge/King’s,
Groningen, Hanover) since 1980, and found that hepatic failure, haemorrhage and
operative/technical factors contributed 57% of the failures that occured in less than
three months from operation, and this resulted in the deaths of 31% of patients.
In our initial clinical experience we have employed a method of graft
revascularization differing from that in general use. This method was researched and
published by us many years ago, but it has not been applied clinically until our own
programme started at the beginning of 1986. The method has been used in 11 patients
who received liver grafts at least three months ago. There was good immediate
function in all grafts. Nine of these patients (82%) are now surviving between 4 and
18 months (mean 11 months) since transplantation.
MATERIALS AND METHODS
Donors
Donors were individuals less than 50 years of age who had been certified as brain
dead. Donor hepatectomy was always part of multiple organ procurement. Skilled
anaesthetic support was provided during the operation for maintenance of
haemodynamic stability by means of infusions of electrolytes, colloid solutions and
blood. Before interruption of the circulation, herapin (30 000 IU if adult and 15 000
IU if paediatric) and methylprednisolene (lg adult; 500 mg paediatric) were
administered.
The methods used for donor hepatectomy were modified from those described by
others9’11. However, we avoid all manipulations of the abdominal organs to be
removed (usually the liver and kidneys) until the organs are cold-perfused. We have
dubbed this the "no touch" technique. Briefly, a full-length incision from the
suprasternal notch to the pubis is made. The common bile duct, gastroduodenal,
splenic and left gastric arteries are divided. The superior mesenteric and splenic veins
are isolated behind the head of the pancreas. The origin of the superior mesenteric
artery is encircled. The infrarenal aorta is dissected free and cannulated for perfusion
purposes, with ligation of the inferior mesenteric artery. After heparinization, the
superior mesenteric artery, splenic vein and superior mesenteric vein ligated and a
cannula is inserted into the portal vein through the superior mesenteric vein.
Sponges soaked in saline ice slush solution are placed over the liver and both kidneys.
The abdominal cavity is filled with saline ice slush solution. Cold portal perfusion
with an oxygenated human albumin solution that has electrolyte concentrations
similar to that of extracellular fluid (Table 1) is begun and, if the heart is for
transplatation, the cardiac team moves at once to remove the heart. At this time, the
aorta is clamped in the lower chest, and organ perfusion via the cannulated
abdominal aorta begins. The inferior vena cava is allowed to drain freely into the
chest where it has been divided from the heart. If the heart is not to be removed, the
right atrium is incised to allow free venous decomposition. Blood and perfusion fluid
are removed from the chest cavities by suction. A total of approximately 100 ml ofLIVER GRAFT REVASCULARIZATION 59
Table Initial liver perfusion fluid: concentrations of electrolytes and other constituents.
Consituent Concentration
Sodium 145 mM/1
Potassium 2.7 mM/1
Chloride 120 mM/1
Glucose 5 mM/1
Calcium 2 mM/1
Magnesium 1.3 mM/1
Albumin 45 g/1
Mannitol g/l
Heparin 500 IU/1
Ampicillin g/l
Hydrocortisone 200 mg/1
pH 7.4 IU
pOz 312 _+ 74 mmHg
Osmolality 320 mOsm/l
One-litre amounts made up in 2-1itre bags, which distended with sterile oxygen.
Subsequent perfusion fluid: Red blood cells cross-matched against donor and recipient added to the perfusion fluid to give haematocrit
of 13% for cold and perfusion immediately prior to revascularization.
perfusion fluid per kilogram body weight is used. After 5-10 min exsanguination and
perfusion are complete. The cold saline solution is removed from the abdominal
cavity by suction. All mesenteric attachments of the bowel are divided and the bowel
is removed from the abdominal cavity, fully exposing the retroperitoneum. The liver
and kidneys are then carefully dissected while being protected at all times with cold
sponges.
The liver is transported immersed in the same perfusion fluid as used for perfusion.
Recipients
Recipients were four children aged 2-17 (mean (m) 12) years and seven adults aged
20-50 (m 37) years. Causes of hepatic failure were primary sclerosing cholangitis [4
cases], secondary biliary cirrhosis [2], alpha-1 antitrypsin deficiency [2], primary
biliary cirrhosis [1], tyrosinaemia [1], and Wilson’s disease [1]. Four (36%) recipients
fell into the high-risk group defined by Shaw et al.
4 because of portal vein thrombosis
after a previous meso-caval shunt 1], previous porto-caval shunt [1], multiple biliary
operations with intra-duct stones and pancreatic abscess [1], and advanced cahexia
with persistent variceal haemorrhage and encephalopathy [1].
The methods used for implantation of the livers were again modelled upon those of
the pioneers of liver transplantation, including the use in adults of veno-venous by-
pass methods without the administration of heparin during the anhepatic interval5.
However, at the same time as the left groin was prepared for veno-venous by-pass,
the left superficial femoral artery was isolated for subsequent insertion of an iliac
arterial shunt. When the recipient liver had been prepared for removal, veno-venous
by-pass was established and a clamped arterial cannula filled with heparinized saline
was inserted via the left superficial femoral artery into the left external iliac artery.
The recipient liver was then excised. After completion of the first anastomosis [the
suprahepatic inferior vena cava (SHIVC) at the level of the diaphragm], the liver was
perfused with cold oxygenated perfusate now containing red blood cells cross-60 A.G.R. SHEIL et al.
matched against both donor and recipient to a haematocrit of 13%. The caval
anastomosis, hilar region and retrophepatic caval area were inserted for leakage, and
any defects were secured. Effluent was allowed to flow freely from the unclamped
infrahepatic IVC. Samples were taken for analysis at the beginning of, during and at
the completion of perfusion.
In the first three patients the method of revascularization by means of an arterio-
portal shunt was tested only after the infrahepatic IVC and arterial anastomoses
were completed, but not released. The arterial shunts into the graft portal veins were
opened as the sole method of revascularization for 10, 15 and 20 min during the first,
second and third operations, respectively. When it was found to be safe, the
following procedure was standard for the remaining eight patients.
After completion of the SHIVC anastomosis and testing with cold perfusion, the
allograft was perfused with the same solution warmed to 37C. Further samples from
the infrahepatic IVC were taken at this time. Approximately 1000 ml of perfusate
was used and liver temperatures were monitored. When the liver core temperature
exceeded 22C perfusion ceased, the infrahepatic IVC was occluded and the iliac
artery cannula was attached to the in-dwelling portal vein cannula used for perfusion
purposes. The suprahepatic IVC clamp was removed and also the clamp on the iliac
artery shunt, resulting in graft revascularization (Figure 1). If necessary, flows
through the arterial shunt into the donor portal vein, measured by means of an
electromagnetic flowmeter, were regulated to be less than 1000 ml per min.
Haemostasis was again confirmed. The infra-hepatic IVC anastomosis was then
Figure 1 The suprahepatic IVC anastomis has been completed. Revascularization follows at once by
joining the iliac artery shunt to the donor portal vein perfusion catheter as shown. The portal limb of the
recipient veno-venous bypass is also illustrated. The infrahepatic IVC anastomosis is being performed.LIVER GRAFT REVASCULARIZATION 61
completed and released with removal of the systemic limb of the veno-venous
bypass. The hepatic arterial anastomosis was then performed and released. On one
occasion two donor hepatic arteries required anastomosis. If there was any doubt
concerning the adequacy of arterial flow, flow measurements were made and, if the
flow was unsatisfactory (less than 4 ml/kg) body weight), the anastomosis was
redone. This happened on one occasion. Only when arterial flows and systemic
blood pressures were satisfactory were the portal venous anastomoses performed,
preceded by removal of the iliac artery shunt from the donor portal vein and the
portal limb of the veno-venous bypass from the recipient portal vein. Biliary outflow
was established by choledochocholedochostomy or by choledochojejunostomy.
Wedge hepatic biopsies were taken before wound closure.
RESULTS
Total ischaemic intervals for the liver allografts were 3 h 36 min 7 h 51 min (average
5 h 10 min). Anhepatic intervals for the recipients were 55 min- 2 h 15 min (average
1 h 55 min). The blood transfusions required during operation numbered 3- 73 units
(m 30 units). With the exception of the first three patients, the arterio-portal shunts
were open for 18-85 (m46) min. Blood flows through the shunts measured 250-520
(m 352) ml/min, except on two occasions when flows of 1200 and 1500 ml/min were
recorded on opening the shunts and in these cases the flows were mechanically
adjusted to be less than 1000 ml/min. Pressures within the portal veins measured
while the arterio-portal shunts were operating were 11-25 mmHg and were similar to
the central venous pressures recorded at the same time.
At the time of revascularization there was no serious haemorrhage in any patient.
There was no significant change in the heart rate in eight patients, while the heart rate
increased by up to 15 beats per min in the other three. There was a fall in the mean
arterial pressure at the time of revascularization from 92 +_ 14mmHg (mean +s.d) to
83 + 13 mmHg. Recovery of blood pressure to pre-revascularization levels had
occurred usually within 5 min and always within 15 min. The cardiac index increased
in 10 of the patients from a mean of 5.67 + 1.95 1/min/m2 to a mean of 7.6 +_ 4.1 1/
min/m2. Although the cardiac index had reduced to 6.52 _+ 3.36 1/min/m2 within 15
min, it remained at an increased level throughout the operation, final estimates being
6.09 + 3.33 1/min/m2. Arterial blood pH values fell from 7.3 + 0.13 units to 7.23 _+
0.12 units at the time of revascularization. Ionized calcium levels decreased from 0.9
+ 0.26 mmol/1 to 0.79 +_ 0.18 mmol/l. An immediate short-lived rise in serum
potassium levels at the time of revascularization (mean peak value 3.7 + 1.1 mmol/1)
was followed by a sustained fall in values to below baseline levels (2.8 + 0.6 mmol/1).
Blood coagulation studies after revascularization showed a brief prolongation of the
activated partial thromboplastin time (APTT) from 51 +_ 27 s to 79 + 48 s with
essentially stable prothrombin index and blood platelet counts.
Biochemical analyses of samples taken of the effluent from the infrahepaticIVC at
the times of cold perfusion andwarm perfusion immediately before revascularization
showed variations from the inflowing perfusion fluids particularly in the levels of
potassium (K+) and of the hepatic cellular enzymes alanine amino-transferase
(ALT) and aspartate amino-transferase (AST). These levels were greatly elevated
but reduced progressively during the wash-outs as shown in Table 2. Blood gas
analysis and pH determinations revealed a fall in the oxygen tension in the warm62 A.G.R. SHEIL et al.
Table 2 Levels of potassium (K+), alanine amino-transferase (ALT) and aspartate amino-transferase
(AST) in the hepatic allograft effluent perfusate at the geginning and end of cold and warm perfusion.
Coldperfusion Warmperfusion
Beginning End Beginning End
K mmol/l
ALT units/l
AST units/l
14.7-37.9 (m 22.3) 11.4-29.8 (m 18.1) 6.2-27.9 (m 11.2) 3.8-11.7 (m 6.4)
567-28000(m9078) 118-14000(m6511) 126-11020(m2839) 252-2679(m998)
693-25000 (m 8455) 210-3378 (m 4306) 256-4173 (m 2399) 197-2334 (m 918)
Normal values for ALT and AST in laboratory 5-55 units/l.
perfusate from 440 + 126 mmHg to 45 + 26 mmHg after traversing the liver, while
there was a decrease of 0.36 + 0.12pH units.
Microscope examination of the wedge biopsy specimens taken from all livers at the
end of the operations regularly revealed the presence of a thin layer of subcapsular
hepatic necrosis thought to be associated with graft manipulation. Otherwise the
graft cells were uniformly viable and the hepatic architecture well preserved.
In all 11 patients there was immediate evidence of function of the allografts as
secretion of copious amounts of normally pigmented bile occured. All patients
recovered promptly from the operation, with the exception of one who developed
fitting, leading to cerebral anoxia and ultimately death. A second patient died of
cerebral haemorrhage 10 days after operation. In all nine other patients evidence of
continuing progressive improvement in liver function was clear. In all,
haematological parameters, with the exception of platelet counts, were close to
normal from the time of operation. At 24 h and 48 h postoperativelyAST levels in the
blood were 126-691 (m 274) units/1 and 60-352 (m 160) units/1. ALT levels at these
times were 152-765 (m 340) units/l and 83-668 (m 320) units/1. The levels of these
enzymes and of the serum bilirubin fell continuously thereafter unless interrupted by
rejection activity. Radioisotope liver scans (HIDA) performed on the day of
operation or on the first or second postoperative days were always reported to show
satisfactory hepatic function. Strongly pigmented bile was secreted by all patients in
volumes allowing 200-400 ml per day to drain via the T-tubes. All nine (82%) remain
alive and well 4-18 (m I1) months since transplantation, although two have impaired
hepatic function because of biopsy-confirmed chronic rejection.
DISCUSSION
The number of parameters involved in early postoperative good function in human
liver allografts is so great that analysis of the role played by various factors is
extremely difficult. Most parameters are non-immunological. Crucial factors include
the physical state of the donor, donor liver and recipient, the pre-operative and intra-
operative management of both donor and recipient together with the operative
techniques employed, the fluids and methods used for preservation, and the
postoperative management of the recipient.
For these reasons we are uncertain of the relative importance of the methods used
here for donor hepatectomy, liver preservation and graft implantation. AfterLIVER GRAFT REVASCULARIZATION 63
experimental work in pigs that resulted in improved laboratory success rates in our
hands8 we simply translated the methds in totality to the clinical sphere. Since
deficiency in any aspect of overall management usually leads to failure in liver
transplantation
9 it seems likely that all the methods used by us are at least
satisfactory, as all the transplanted livers functioned well.
The methods we used for donor hepatectomy were modelled on those of Starzl et
al1. We do not, however, use their "pre-cooling" method of cold infusion into the
liver via the splenic vein during the early dissection of the liver. Instead we prefer not
to dissect the organs but to minimize operating time and the risks of donor
hypotension by performing cold perfusion via vessels remote from the liver and
kidneys. This technique is more akin to the "fast" donor operation described by
Starzl et al. 11 and recently further elaborated12. By these methods all trauma caused
by manipulations of the organs to be removed is avoided, together with any effects of
arterial vasospasm that might occur as a results of dissection involving the arteries of
supply to the organs.
We also chose to use oxygenated "extracellular" perfusion fluids because of
success in the laboratory experiments. In both the laboratory and clinical work
oxygen was taken up by the allografts during perfusion as revealed by distinct falls in
the oxygen tension in the perfusion solutions after traversing the ischaemic
allografts. While mos.t groups use hyperosmolar solutions containing high levels of
potassium for perfusion, in our hands a simple solution containing human serum
albumin and with electrolyte concentrations similar to extracellular fluid has proved
effective for preservation of all livers, the longest total ischaemic interval being 7 h
and 51 min. Further, serious hyperkalaemia never occurred at revascularization, in
contrast to its variable occurrence in reports from other centres. On the other hand,
biochemical analysis of the effluent from the infrahepatic IVC at the times of cold
and warm perfusions showed changes that reflect some organ damage. Thus, the
levels of potassium were extremely high in the effluent after cold perfusion but had
reduced to acceptable levels by the end of warm perfusion. Similarly, levels ofALT
and AST were very high in the cold perfusate but reduced rapidly as a result of the
cold and warm wash-outs.
The method of graft revascularization whereby arterial blood is shunted into the
donor portal venous system allows revascularization immediately after the
completion of one anastomosis (SHIVC). Without the use of the arterio-portal shunt
most other groups perform the SHIVC anastomosis and then the infrahepatic IVC
and portal venous anastomoses before revascularizing. This method adds to ours the
time required to perform two aditional anastomoses, so increasing the total
ischaemic time for the allograft and the anhepatic period for the recipient. During
this additional time the graft is rewarming in the recipient, making it more vulnerable
to ischaemic damage.
However, we have become wedded to our method of revascularization for a
variety of other reasons. First, cannulation of the superficial femoral artery is a minor
addition to preparation of a groin for veno-venous bypass, which we use regularly
except in small children. Secondly, knowledge that safe liver revascularization can
follow within minutes of completion of the suprahepatic IVC anastomosis
encourages us to undertake meticulous haemostasis during the anhepatic interval
and to perform the top anastomosis with deliberation, these steps accounting for our
average anhepatic interval of I h 55 min. Thirdly, assured absence ofhaemorrhage or
of significant haematological, biochemical or acid-base abnormalities at the time of64 A.G.R. SHEIL et al.
revascularization is reassuring for both the surgical and the anaesthetic teams.
Fourthly, a technical advantage is that the posterior aspect of the suprahepatic IVC
anastomosis and the retrohepatic region are still available for inspection and suture if
required after revascularization, as the liver remains freely mobile on the SHIVC
anastomosis because it is not tethered by an infrahepatic anastomosis. Fifthly, the
method removes the pressures of time constraints on all the anastomoses remaining
after completion of the suprahepatic IVC anastomosis. Because the liver is safely
revascularized, each anastomosis can be done without hurry, satisfactory blood flow
can be confirmed and if need be, anastomoses can be redone. Finally, the method
provides the capability for dealing with unexpected complications that may develop
during the procedure, as in two cases mentioned below.
The possibility that the method of revascularization might be damaging to the
allograft was a matter of prime concern initially. However, with the flow rate from
the arterial shunt into the portal vein either being less then normal portal flow when
unrestricted or being adjusted to approximate normal flows, it is logical, and we have
confirmed, that blood pressures within the portal system are close to normal portal
pressures. Flow via the shunt is continuous and only gently pulsatile, as is the case in
arterio-venous fistulas, and as evidenced by flow meter recordings and a continuous
thrill palpable in the donor portal vein while the shunts were operational. With
normal flows and pressures in the portal system it seems highly unlikely that
haemodynamic damage could result. However, there is the further consideration
that the presence of arterial concentrations of oxygen within the portal system, as
opposed to the usual lower oxygen concentrations of portal blood, might be
damaging. All the evidence that we can gather relating to this matter indicates that
no specific hepatic cellular or other damage results from the method. Thus, animals
with arterialization of the portal vein can survive for long periods with good hepatic
function until the haemodynamic effects of the fistulas begin to take effect13; hepatic
malfunction is relatively rare in the short term after arterio-portal fistulas14; and all
haematological, biochemical and histological evidences from our own experimental
works showed comparatively minor damage after orthotopic liver transplantation
when this method of revascularization was used. These observations are confirmed in
the clinical study reported here, where the degree of graft damage as assessed by the
early postoperative blood levels of liver cellular enzymes was modest, and
microscopy of liver biopsy specimens taken at the end of the operations showed the
preservation of normal hepatic architecture. Further, there was every indication of
good early graft function virtually from the time of revascularization and continuing
thereafter.
A factor that we think may have some importance is that in our method of
revascularization arterial blood is provided to the ischaemic graft, whereas it is
common practice to revascularize with portal venous blood. In the latter case the
graft then remains without arterial blood for a further 15-20 min while the arterial
anastomosis is completed. There are uncertainties in our minds as to whether
revascularization with blood released from the obstructed portal circulation is always
beneficial to the ischaemic allograft. It seems possible to us that in a small proportion
of liver grafts, perhaps those already damaged by other factors, irrecoverable injury
may occur during the time they are supported by portal venous blood alone, and that
this may explain otherwise inexplicable cases of primary non-function of liver grafts.
This concern is underlined by the sometimes catastrophic consequences of_ arterial
thrombosis in the early post-transplant days, in which situation the newly implantedLIVER GRAFT REVASCULARIZATION 65
liver is supported with portal blood only.
If this reasoning proves correct it will be asked why it would not be more logical to
shunt blood to the donor hepatic artery or revascularize after the hepatic
anastomosis alone. However, these are not attractive alternatives because of the
frequency of multiple hepatic arteries, the possibility of vasospasm or arterial
damage resulting from the arterial manipulations, and concern should the arterial
anastomosis not be perfect or should hypotension develop for any reason. If
inadequacy of arterial supply occured for any reason at this stage, the consequences
could be catastrophic, as after revascularization the liver graft is rewarmed and so
highly susceptible to damage from ischaemia. With our method, as long as it
necessary can be taken to ensure a normal arterial supply to the entire graft, and
during this period the graft is perfectly perfused via the portal vein with arterial
blood. Also in two cases where severe hypotension developed, once before and once
after liver revascularization (because of variceal haemorrhage in the former and
haemorrhage during disconnection of a porto-caval shunt in the latter), we have
established that satisfactory blood flows of 200-300 ml/min pass through the arterial
shunt into the low pressure portal system despite serious hypotension. It was, we
believe, life-saving to be able to achieve urgent revascularization in the first case and
to maintain satisfactory graft perfusion by means of the arterial shunt in both cases
while these complications were dealt with.
Because of our inexperience in clinical transplantation and because we have no
control series of patients, historical or concurrent, we cannot be certain whether our
method of revascularization has sufficient advantages to warrant adding a further
complicating manoeuvre to an already complicated procedure. Our conclusion is
that the method is an alternative way to revascularize liver grafts that is safe and that
may have some advantages. It has allowed us to encompass satisfactorily the initial
phase of our clinical programme despite a significant proportion of high-risk
patients.
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